Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M234Revenue $M45.0Net Margin (%)14.1Altman Z-Score12.8
Enterprise Value $M194EPS $0.3Operating Margin %12.0Piotroski F-Score4
P/E(ttm)37.2Beneish M-Score0.9Pre-tax Margin (%)14.3Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio5.8Cash flow > EarningsN
Price/Sales5.45-y EBITDA Growth Rate %--Current Ratio8.0Lower Leverage y-yY
Price/Free Cash Flow520y-y EBITDA Growth Rate %-73.1ROA % (ttm)4.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)4.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M22.5ROIC % (ttm)5.8Gross Margin Increase y-yY

Gurus Latest Trades with ENZY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZYJohn Paulson 2014-03-31 Sold Out -0.23%$21.52 - $29.5
($26.63)
$ 10.40-61%Sold Out0
ENZYJohn Paulson 2013-12-31 Buy 0.23%$16.555 - $33.44
($23.85)
$ 10.40-56%New holding1,733,030
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ENZY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ENZY :

Quarterly/Annual Reports about ENZY:

    News about ENZY:

    Articles On GuruFocus.com
    ENZYMOTEC 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General a Oct 31 2014 
    Kessler Topaz Meltzer & Check, LLP Reminds Enzymotec Ltd. (ENZY) Shareholders of Class Action Lawsui Oct 15 2014 
    Saxena White P.A. Files Securities Fraud Class Action Against Enzymotec Ltd. Oct 15 2014 
    What Drives St. Jude Medical to Be More Diversified? Apr 30 2014 

    More From Other Websites
    Enzymotec (ENZY) Worth a Look: Stock Up 5.1% in Session Aug 31 2015
    Enzymotec Ltd. Granted U.S. Patent for INFAT(R) to Promote Intestinal Development and Maturation Aug 20 2015
    Enzymotec Ltd. Granted U.S. Patent for INFAT(R) to Promote Intestinal Development and Maturation Aug 19 2015
    Will Enzymotec (ENZY) Continue to Surge Higher? Aug 17 2015
    Enzymotec (ENZY) Catches Eye: Stock Soars 15.2% Aug 13 2015
    Enzymotec upgraded by Wells Fargo Aug 13 2015
    Enzymotec Ltd. Reports Second Quarter 2015 Results Aug 12 2015
    Enzymotec beats 2Q profit forecasts Aug 12 2015
    Enzymotec beats 2Q profit forecasts Aug 12 2015
    Enzymotec Ltd. Reports Second Quarter 2015 Results Aug 12 2015
    Q2 2015 Enzymotec Ltd Earnings Release - Before Market Open Aug 12 2015
    Enzymotec Ltd. Announces the Appointment of Tamar Howson to Its Board of Directors Jul 30 2015
    Enzymotec to Report Second Quarter 2015 Financial Results Jul 29 2015
    Enzymotec to Report Second Quarter 2015 Financial Results Jul 29 2015
    Enzymotec Ltd. Announces Investigator Initiated Clinical Trial of Vayarin(R) in Managing ADHD in... Jul 07 2015
    Enzymotec Ltd. Announces Investigator Initiated Clinical Trial of Vayarin(R) in Managing ADHD in... Jul 07 2015
    2015-06-15 Enzymatica rang in the company at Nasdaq First North Jun 15 2015
    Enzymotec Ltd. Announces Annual General Meeting of Shareholders Jun 11 2015
    2015-06-10 Enzymatica approved for listing on Nasdaq First North - trading to start June 15, 2015 Jun 10 2015
    Will Enzymotec (ENZY) Continue to Surge Higher? - Tale of the Tape May 28 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK